Table 2.
Serum biochemistry profile of the study patients
| Non-Diabetic (n = 2181) | Good-control DM (n = 291) | Poor-control DM (n = 412) | P-value* | P-value† | P-value‡ | |
|---|---|---|---|---|---|---|
| LDL-C (mmol/l) |
2.52 ± 1.02 |
2.43 ± 0.92 |
2.51 ± 1.15 |
0.12 |
0.80 |
0.33 |
| HDL-C (mmol/l) |
1.05 ± 0.28 |
1.05 ± 0.28 |
1.08 ± 0.56 |
0.95 |
0.27 |
0.36 |
| TCH (mmol/l) |
4.38 ± 1.18 |
4.28 ± 1.16 |
4.50 ± 1.35 |
0.17 |
0.10 |
0.02 |
| TG (mmol/l) |
1.90 ± 1.10 |
1.93 ± 1.09 |
2.15 ± 1.17 |
0.68 |
<0.0001 |
0.01 |
| FPG (mmol/l) |
5.34 ± 0.68 |
7.07 ± 2.14 |
10.19 ± 3.89 |
<0.0001 |
< 0.0001 |
< 0.0001 |
| Mean HbA1c (%) |
- |
6.6 ± 0.7 |
8.8 ± 1.3 |
– |
– |
< 0.0001 |
| Cr (μmol/l) | 100.8 ± 27.6 | 101.3 ± 60.8 | 99.8 ± 32.5 | 0.88 | 0.58 | 0.68 |
Data are presented as mean ± SD.
* Non-diabetic patients versus good-control (diabetic patients with HbA1c ≤ 7%).
† Non-diabetic patients versus poor-control (diabetic patients with HbA1c > 7%).
‡ Good-control versus poor-control diabetic patients.
FPG, fasting plasma glucose; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TCH, total cholesterol; TG, triglycerides; Cr, creatinine.